期刊文献+

经桡动脉冠状动脉介入治疗的疗效和安全性评价 被引量:2

TREATMENT OUTCOME AND SAFETY OF CORONARY ARTERY INTERVENTIONAL THERAPY VIA RADIAL ARTERY
下载PDF
导出
摘要 ①目的探讨经桡动脉冠状动脉介入治疗不稳定型心绞痛和急性心肌梗死的临床效果及安全性.②方法对98例冠心病病人采用经桡动脉径路介入治疗(TRI组),118例病人采用股动脉途径进行介入治疗(TFI组).观察比较两组穿刺成功率,手术成功率,手术时间,X线照射时间,病人住院时间,并发症发生率(穿刺部位出血、血肿等).③结果穿刺成功率、手术成功率、置入支架情况、手术时间和X线照射时间,两组间比较无统计学意义(x2=2.07、2.18,t=1.02~1.26,P>0.05);TRI组病人的住院时间小于TFI组(t=2.35,P<0.05).④结论经桡动脉冠状动脉介入治疗不稳定型心绞痛和急性心肌梗死是有效、安全的,可减少病人的住院时间. Objective To evaluate the results and safety of coronary artery interventional therapy via radial artery.Methods From September 2003 to October 2004, 216 cases undergoing coronary artery interventional therapy were divided into two groups; radial (TRI group, n=98) and femoral (TFI group, n=118). X ray irradiation time, operating time, operating and puncture success rate as well as complications were observed. Results X-ray irradiation time, operating time, operating and puncture success rate and complications were of no difference in the two groups (x^2=2.07,2.18;t=1.02-1.26;P〉0.05). TRI group was less hospital stay than that of TFI group (t=2.35 ,P〈0.05). Conclusion Coronary interventional therapy via radial artery is effective and safe for unstable angina and acute myocardial infarction, and may reduce hospital stay.
出处 《青岛大学医学院学报》 CAS 2005年第2期95-96,99,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 冠状动脉硬化 导管插入术 外周 桡动脉 治疗结果 coronary arteriosclerosis catheterization peripheral radial artery treatment outcome
  • 相关文献

参考文献3

  • 1Shah A, Wagner GS, Granger CB, et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 1-lead ST-segment resultion analysis. Reexamining the gold standard for myocardial reperfusion assessment[J]. J Am Coll Cardiol, 2000,35:666.
  • 2Moses JW, Leon MB,Popma JJ,at al. Sirolimus-eluting stents vers standart stents in patients with stenosis in a native coronary artery[J]. N Engl J Med, 2003,349:1315.
  • 3贾三庆,斋藤滋.TRI的临床经验回顾[A].见:贾三庆,斋藤滋主编.经桡动脉冠状动脉介入治疗[M].北京:中国环境科学出版社,2003.68~70.

同被引文献5

  • 1CANALES J F, FERGUSON J J. Low-molecular-weight hepatins: mechanisms, trials, and role in contemporary interventional medicine[J]. Am J Cardiovasc Drugs, 2008,8(1) : 15-25.
  • 2BARANTKE M, BONNEMEIER H. Factor Xa inactivation in acute coronary syndrome[J].Curr Pharm Des, 2008,14 (12) 1186-1190.
  • 3COLLET J P, MONTALESCOT G, GOLMARD J L, et al. Subcutaneous enoxaparin with early I nvasive strategy in patients with acute coronary syndromes[J]. Am Heart J, 2004, 147(4) :655-661.
  • 4YOUNG J J, KEREIAKES D J, GRINES C L. Low molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National investigators collaborating on enoxaparin investigators [J]. Invasive Cardiol, 2000,12(Suppl E) :E14-28.
  • 5WELSH R C, GORDON P, WESTERHOUT C M, et al. A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary pereutaneous coronary intervention : a west sub-study[J].Catheter Cardiovasc Interv, 2007, 70:341-348

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部